Answers are grounded in this paper and cite their sources.
The biomodulation effect of diode LASER 940 on marginal bone loss (MBL) around implants supporting mandibular hybridprosthesis in controlled diabetic patients was evaluated . Twenty completely edentulous patients with moderately controlleddiabetes mellitus (DM) (glycated hemoglobin (A1c [HbA1c] =8.1%–10.0 %) were selected to participate in this study. Allpatients received upper and lower complete dentures. Four mandibular straight implants were inserted in all patients thenpatients were divided randomly into control group (CG) and Laser group (LG) . In LG diode LASER biomodulation with940nm wavelength with energy 30J and 60 sec was applied around each implant. Both groups were immediately loaded withacrylic interim hybrid prosthesis after modifying complete lower denture . Interim prosthesis used during the follow-up periodtill full patient satisfaction was achieved then a definitive porcelain fused to metal hybrid prosthesis was fabricated. MBL wasmeasured using digital periapical radiographs with standardized long cone paralleling technique at implant loading (0 monthsor baseline), 6 and 12 months. MBL was calculated at T1 (06- months), T6 (612- months) and T12 (012- months) follow-upperiods.LG showed statistically significant lower marginal bone loss MBL than the CG at T1 and no statistically significant differencein MBL at T6 and T12 follow-up periods. Within the limits of this study, low-level LASER biomodulation ( LLLB) maysignificantly decrease the MBL around immediately loaded implants supporting mandibular hybrid prosthesis in controlleddiabetic patients at (T1) but has no effect on MBL in the subsequent (T6 and T12) follow-up periods
No takes yet. Share an insight, caveat, or question.
Elhusseiny et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: